Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Neuromuscul Disord. 2014 Feb 25;24(5):436–444. doi: 10.1016/j.nmd.2014.02.007

Figure 4.

Figure 4

Quantification of MuRF2p50A, MuRF2p60A and MuRF3 transcripts (by ddPCR) at PND01, PND 05, PND08 and PND14 of Smn+/+ Control and SMA animals. (n=3 for each group at each time point) There is no significant difference in MuRF2 and MuRF3 transcripts between control and SMA at any time point. MuRF2 transcripts in (A) skeletal muscle and (B) heart. MuRF3 transcripts in (C) skeletal muscle and (D) heart. (error bars = SEM)